Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling cold on Mounjaro — or noticing a persistent chill that wasn't there before — is something a number of people report in the weeks after starting tirzepatide. It is generally not a sign that something has gone wrong. Reduced calorie intake lowers the amount of heat your body generates, and losing body fat means slightly less insulation; together, these make cold sensitivity a common, expected side effect during weight-loss treatment. That said, the sensation can be uncomfortable, and it is worth understanding what is driving it, how long it tends to last, and when a persistent cold feeling deserves a closer look from your prescriber. These medicines are prescription-only and prescribed following a thorough clinical assessment, so questions about your specific experience are always worth raising with the clinician overseeing your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: it's a Tuesday evening, a few weeks into your Mounjaro treatment. Your appetite is noticeably quieter, the scales are moving, and yet you've reached for a cardigan in weather that would have felt fine before. This is one of the more surprising things people notice on tirzepatide, and it catches many off guard precisely because it is not listed as a headline side effect alongside nausea or constipation.
The mechanism is largely metabolic rather than a direct effect of the medicine in your bloodstream. Tirzepatide works partly by reducing appetite through its dual action on GIP and GLP-1 receptors, which means most people eat considerably less than they did before. Fewer calories consumed means less fuel being burned for heat production. Your body's resting metabolic rate can dip modestly in response, especially in the early weeks when the calorie reduction is most pronounced. Less heat generated equals a body that feels colder in ordinary surroundings.
Body fat also functions as a thermal layer. As the weeks pass and fat tissue reduces, that layer thins. People who lose weight quickly (which tirzepatide can facilitate) sometimes notice this effect earlier than those losing weight more gradually. It is real, it is physical, and it is not your imagination. The NHS patient information for tirzepatide notes decreased appetite and related metabolic changes as recognised aspects of treatment.
For most people, the intensity of cold sensitivity tracks with how steep the calorie reduction is. In the early titration period, when appetite suppression is at its most noticeable relative to your previous intake, the chill can feel most pronounced. As your body adjusts to its new eating pattern (and as your metabolism settles around the new lower weight) many people find the cold feeling moderates on its own.
There is no fixed timeline, because it depends on how much weight you lose, how quickly, and how much your intake has changed. Some people notice it mainly in the first four to eight weeks. Others find it a longer-running feature, particularly if they are losing weight steadily over several months. It is worth tracking whether the sensation is improving, staying the same, or worsening over time, since that pattern is useful information for your prescriber.
Practical things that help in the meantime: keeping well hydrated (mild dehydration amplifies the sensation), prioritising protein at meals to support muscle mass and metabolic rate, and keeping moving. Muscle tissue generates more heat than fat tissue, so even light daily activity makes a noticeable difference. If you want to read more about how to stop feeling cold on Mounjaro, we have a dedicated page covering practical strategies that people have found genuinely useful. If you are curious about how the wider experience of physical sensations on treatment compares, a look at what people report when feeling unwell on Mounjaro puts individual symptoms in useful context.
Cold sensitivity alone, arriving a few weeks into treatment and tracking with weight loss, is usually nothing to escalate. The picture changes if the feeling is severe, worsening rather than stabilising, or sitting alongside other symptoms: persistent fatigue, unexpected hair thinning, constipation beyond the usual GI adjustment period, or a general sense of sluggishness that does not ease. These can occasionally point to a thyroid issue, hypothyroidism produces exactly this cluster, and the thyroid is worth checking if the symptoms stack up. Our page on always feeling cold on Mounjaro goes into more detail about when this pattern is worth taking seriously and what to do next.
This is not a reason to stop treatment without speaking to your prescriber first. It is a reason to mention it. Our clinical team can help work out whether the cold feeling fits the expected pattern or whether something else warrants investigation. You can find out more about the team behind your clinical review on our prescriber profile page.
It is also worth separating feeling cold from feeling cold and unwell. If you have a raised temperature alongside chills, or symptoms that feel more like an infection, that is a different presentation to flag quickly. The MHRA's Drug Safety Updates provide the most current guidance on emerging safety signals for GLP-1 medicines, and any unexpected or distressing symptoms can be reported via the Yellow Card scheme.
Most people work out their own accommodations fairly quickly. Layering works better than one thick layer, since you can adjust through the day. Some people notice the cold most acutely in the late afternoon and evening, when energy from earlier meals has been used up, this is the body's own rhythm, not a cause for concern. It is also worth knowing that some people experience the opposite and find our page on Mounjaro feeling hot a helpful reference for understanding how treatment can affect temperature regulation in both directions.
If you have had Mounjaro delivered over a bank holiday period and you are starting a new pen, remember that storage matters: the pen should have been refrigerated throughout, and you should check the patient information leaflet for the exact details on room-temperature windows before use. Information on injection site technique can also be useful if physical symptoms after injecting are adding to general discomfort.
For anything persistent or concerning, the right move is a conversation with a prescriber. Tirzepatide is a prescription treatment, and feeling cold on Mounjaro is the kind of thing that deserves a real answer from a real clinician, not reassurance from a forum thread. If you are considering starting treatment or have questions mid-treatment, our prescribers review consultations the same day and are available to support you throughout. You can find out about what treatment through a regulated pharmacy looks like on our treatment and consultation page. If you would like a broader overview of what tirzepatide involves, our tirzepatide information page covers the full picture.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.